Macroglossia in endocrine and metabolic disorders: current evidence, perspectives and challenges.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 335, doi. 10.23736/S2724-6507.24.04219-2
- By:
- Publication type:
- Article
Works matching IS 27246507 AND DT 2024 AND VI 49 AND IP 3
Results: 11
1
2
New molecular tools for precision medicine in pituitary neuroendocrine tumors.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 300, doi. 10.23736/S2724-6507.23.04063-0
- By:
- Publication type:
- Article
3
determination of the frequency of hyperprolactinemia-related etiologies and the etiology-specific mean prolactin levels.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 243, doi. 10.23736/S2724-6507.21.03386-8
- By:
- Publication type:
- Article
4
Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomide.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 321, doi. 10.23736/S2724-6507.23.04058-7
- By:
- Publication type:
- Article
5
Proteomics for the identification of peripheral markers in pituitary disease.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 293, doi. 10.23736/S2724-6507.23.04075-7
- By:
- Publication type:
- Article
6
How to standardize the diagnostic approach to pituitary neuroendocrine tumors.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 283, doi. 10.23736/S2724-6507.24.04079-X
- By:
- Publication type:
- Article
7
Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 269, doi. 10.23736/S2724-6507.24.04126-5
- By:
- Publication type:
- Article
8
Intact luteinizing hormone, LHβ, and LHβ core fragment in urine of menstruating women.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 262, doi. 10.23736/S2724-6507.22.03565-5
- By:
- Publication type:
- Article
9
long-term clinical sequelae and socio-professional performance in craniopharyngioma patients.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 253, doi. 10.23736/S2724-6507.22.03719-8
- By:
- Publication type:
- Article
10
The effects of cabergoline in the presurgical and recurrence periods of Cushing’s disease patients.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 235, doi. 10.23736/S2724-6507.21.03622-8
- By:
- Publication type:
- Article
11
Highlights of the July-September 2024 issue.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 3, p. 233, doi. 10.23736/S2724-6507.24.04268-4
- By:
- Publication type:
- Article